Mahajan P B, Gokal P K, Thompson E A
Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston 77550.
J Biol Chem. 1990 Sep 25;265(27):16244-7.
Glucocorticoids inhibit transcription of rDNA in P1798 lymphoma cells. This observation can be recapitulated in vitro in that extracts from hormone-treated cells are virtually incapable of transcribing from the cloned mouse rRNA promoter. However, such extracts can be reconstituted by addition of a RNA polymerase I transcription factor, called TFIC. TFIC has been purified to homogeneity. Assays have been developed which facilitate analysis of various aspects of initiation of transcription by RNA polymerase I in vitro. This paper describes a series of experiments designed to test two related hypotheses. It is proposed that TFIC is a bona fide initiation factor and that the inability of hormone-treated cells to synthesize rRNA is due to failure to form initiation complexes on rDNA. The data indicate that extracts from hormone-treated cells cannot form KCl or heparin-resistant initiated complexes upon the rRNA promoter. The ability to form such complexes is dependent upon the addition of TFIC. The lack of TFIC precludes formation of the first phosphodiester bond. At low concentrations of TFIC there is a more or less direct relationship between the amount of the factor and the number of initiated complexes formed. At higher concentrations, the system saturates and addition of TFIC beyond 80 pg/microliters (approximately 0.5 nM) has no effect upon initiation. Addition of TFIC to control extracts does not influence the formation of initiated complexes. This is consistent with the conclusion that control extracts contain excess TFIC, whereas hormone-treated extracts are depleted in this respect. The kinetics of reconstitution have been examined, and the results suggest that association of highly purified TFIC with the transcriptional apparatus is a relatively slow process, with a t1/2 of about 2 min. The data are consistent with the hypothesis that TFIC is an initiation factor and suggest that the active form of RNA polymerase I is associated with TFIC. It is proposed that in the absence of this association, initiation of transcription of rDNA does not occur.
糖皮质激素抑制P1798淋巴瘤细胞中rDNA的转录。这一观察结果可在体外重现,即激素处理细胞的提取物几乎无法从克隆的小鼠rRNA启动子进行转录。然而,通过添加一种名为TFIC的RNA聚合酶I转录因子,可以使此类提取物恢复转录能力。TFIC已被纯化至同质。现已开发出多种检测方法,便于在体外分析RNA聚合酶I转录起始的各个方面。本文描述了一系列旨在检验两个相关假设的实验。有人提出,TFIC是一种真正的起始因子,激素处理细胞无法合成rRNA是由于未能在rDNA上形成起始复合物。数据表明,激素处理细胞的提取物无法在rRNA启动子上形成对KCl或肝素具有抗性的起始复合物。形成此类复合物的能力取决于TFIC的添加。缺乏TFIC会阻止第一个磷酸二酯键的形成。在低浓度的TFIC下, 该因子的量与形成的起始复合物数量之间或多或少存在直接关系。在较高浓度下,系统会饱和,添加超过80 pg/微升(约0.5 nM)的TFIC对起始没有影响。向对照提取物中添加TFIC不会影响起始复合物的形成。这与以下结论一致:对照提取物含有过量的TFIC,而激素处理的提取物在这方面则有所减少。已对重组动力学进行了研究,结果表明,高度纯化的TFIC与转录装置的结合是一个相对缓慢的过程,半衰期约为2分钟。这些数据与TFIC是一种起始因子的假设一致,并表明RNA聚合酶I的活性形式与TFIC相关。有人提出,在不存在这种结合的情况下,rDNA的转录起始不会发生。